I. Yamamoto

I. Yamamoto, E. Gohda, T. Matsunaga, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.

I. Yamamoto, E. Gohda, T. Matsunaga, 1994, Experimental cell research.

Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors.

M. Tanaka, I. Yamamoto, M. Hatanaka, 1990, Biochemical and biophysical research communications.

Augmentation of the antibody response by lipoic acid in mice. I. Analysis of the mode of action in an in vitro cultures system.

I. Yamamoto, T. Yamauchi, Ohmori Hnt, 1986, Japanese journal of pharmacology.

REGULATION OF GENE EXPRESSION AND PRODUCTION OF HEPATOCYTE GROWTH FACTOR (HGF)

I. Yamamoto, E. Gohda, 1993 .

Tissue distribution and characteristics of xanthine oxidase and allopurinol oxidizing enzyme.

H. Iwata, I. Yamamoto, E. Gohda, 1976, Japanese journal of pharmacology.

Modulation of hepatocyte growth factor induction in human skin fibroblasts by retinoic acid.

H. Tsubouchi, I. Yamamoto, E. Gohda, 2005, Biochimica et biophysica acta.

Nerve growth factor enhances antigen-specific antibody production in ascorbate-stimulated murine splenocytes.

M. Yanagida, I. Yamamoto, E. Gohda, 1996, Life sciences.

Differential changes in atrial natriuretic peptide and vasopressin receptor bindings in kidney of spontaneously hypertensive rat.

I. Yamamoto, T. Ogura, N. Ogawa, 1987, Life sciences.

Stimulation of hepatocyte growth factor production in human fibroblasts by the protein phosphatase inhibitor okadaic acid.

I. Yamamoto, E. Gohda, T. Nagao, 2000, Biochemical pharmacology.

Requirement of cytokines for augmentation of the antigen-specific antibody responses by ascorbate in cultured murine T-cell-depleted splenocytes.

I. Yamamoto, H. Mitsuzumi, T. Kurimoto, 1998, Japanese journal of pharmacology.

Further investigation on the carcinostatic activity of 4(or 5)-aminoimidazole-5(or 4)-carboxamide derivatives: structure-activity relationship.

A. Akashi, H. Iwata, I. Yamamoto, 1968, Gan.

Pharmacological studies on 4 (or 5)-aminoimidazole-5 (or 4)-carboxamide (AICA) derivatives.

A. Akashi, I. Yamamoto, K. Hano, 1967, Japanese journal of pharmacology.

Human hepatocyte growth factor in blood of patients with fulminant hepatic failure

S. Hirono, H. Tsubouchi, I. Yamamoto, 1991, Digestive Diseases and Sciences.

Purification and characterization of a mouse hepatocyte growth-stimulating factor from the liver of carbon tetrachloride-treated mice.

I. Yamamoto, E. Gohda, T. Matsunaga, 1992, Journal of pharmacobio-dynamics.

Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin

M. Nishibori, Hideo Takahashi, S. Mori, 2003, Cell and Tissue Research.

Activation of Murine Peritoneal Macrophages by Water-Soluble Extracts of Bursaphelenchus xylophilus, a Pine Wood Nematode

H. Kanzaki, A. Tai, I. Yamamoto, 2006, Bioscience, biotechnology, and biochemistry.

Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.

I. Yamamoto, M. Fujiwara, K. Mitsui, 1990, Japanese journal of pharmacology.

Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma.

H. Tsubouchi, I. Yamamoto, E. Gohda, 2004, Biochemical and biophysical research communications.

Promotion of IL-4- and IL-5-dependent differentiation of anti-mu-primed B cells by ascorbic acid 2-glucoside.

A. Tai, I. Yamamoto, E. Gohda, 2009, Immunology letters.

β‐Cyclodextrin as a substitute for fetal calf serum in the primary antibody response in vitro

H. Ohmori, I. Yamamoto, 1987, European journal of immunology.

Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition.

T. Sotani, I. Yamamoto, E. Gohda, 2003, Biochemical pharmacology.

Augmentation by 2‐Mercaptoethanol of In Vitro Anti‐TNP Antibody Production Induced by Butyrate Plus IL‐2 in Murine Splenic B Cells

E. Aoyama, I. Yamamoto, E. Gohda, 2003, Immunopharmacology and immunotoxicology.

Hepatocyte growth factor--pleiotropic cytokine produced by human leukemia cells.

S. Nakamura, J. Minowada, I. Yamamoto, 1995, Leukemia & lymphoma.

Properties of hydrogen peroxide-induced histamine release from rat mast cells.

H. Ohmori, I. Yamamoto, K. Tasaka, 1980, Biochemical pharmacology.

Effects of Rooibos Tea Extract on Antigen-specific Antibody Production and Cytokine Generation in Vitro and in Vivo

A. Tai, I. Yamamoto, K. Kunishiro, 2001, Bioscience, biotechnology, and biochemistry.

Effect of chlorpromazine on enzymic reactions involving metal ions.

I. Yamamoto, A. Tsujimoto, Y. Kurogochi, 1960, Japanese journal of pharmacology.

Effect of chlorpromazine on the cell metabolism.

I. Yamamoto, A. Tsujimoto, Y. Kurogochi, 1957, Japanese journal of pharmacology.

Production of hepatocyte growth factor by human haematopoietic cell lines.

S. Nakamura, J. Minowada, I. Yamamoto, 1994, Cytokine.

Stimulation of DNA synthesis in skin fibroblasts by human hepatocyte growth factor/scatter factor.

I. Yamamoto, E. Gohda, T. Matsunaga, 1993, Cell biology international.

Human hepatocyte growth factor stimulates the growth of HUH-6 clone 5 human hepatoblastoma cells.

M. Namba, M. Miyazaki, H. Tsubouchi, 1992, Cell biology international reports.

TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts.

I. Yamamoto, E. Gohda, T. Matsunaga, 1992, Cell biology international reports.

An experimental model of nephritis induced by calf serum injection in mice.

E. Matsuura, I. Yamamoto, K. Hosoda, 1984, Japanese journal of pharmacology.

In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin

I. Yamamoto, N. Yamamoto, S. Homma, 1993, Cancer Immunology, Immunotherapy.

Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells

I. Yamamoto, E. Gohda, Kayoko Kanasaki, 2002, Brain Research.

The effect of salazosulfapyridine on the in vitro antibody production in murine spleen cells.

I. Yamamoto, M. Fujiwara, K. Mitsui, 1990, Immunopharmacology.

Enzyme immunoassay of cyclic adenosine 3′,5′-monophosphate (AMP) using β-d-galactosidase as label

I. Yamamoto, J. Tsuji, 1981 .

Enzymatic formation of a nonreducing L-ascorbic acid α-glucoside: Purification and properties of α-glucosidases catalyzing site-specific transglucosylation from rat small intestine

I. Yamamoto, Tomoe Y. Nakamura, N. Muto, 1990 .

Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin.

A. Tai, I. Yamamoto, E. Gohda, 2005, Biological & pharmaceutical bulletin.

Enhancement by ascorbic acid 2-glucoside or repeated additions of ascorbate of mitogen-induced IgM and IgG productions by human peripheral blood lymphocytes.

I. Yamamoto, E. Gohda, N. Muto, 1994, Japanese journal of pharmacology.

Mechanism of augmentation of the antibody response in vitro by 2- mercaptoethanol in murine lymphocytes. I. 2-Mercaptoethanol-induced stimulation of the uptake of cystine, an essential amino acid

H. Ohmori, I. Yamamoto, 1982, The Journal of experimental medicine.

Collagen synthesis in human skin fibroblasts is stimulated by a stable form of ascorbate, 2-O-alpha-D-glucopyranosyl-L-ascorbic acid.

I. Yamamoto, N. Muto, K. Murakami, 1992, The Journal of nutrition.

Augmentation of Antigen-Specific Antibody Production and IL-10 Generation with a Fraction from Rooibos (Aspalathus linearis) Tea

A. Tai, I. Yamamoto, K. Ichiyama, 2007, Bioscience, biotechnology, and biochemistry.

Antitumor activity of 4 (or 5)-aminoimidazole-5 (or 4)-carboxamide derivatives.

A. Akashi, I. Yamamoto, I. Ninomiya, 1965, Gan.

Augmentation of in vitro antibody response by disulfide compounds. II. T cell-mediated augmentation by oxidized dithiothreitol, an intramolecular disulfide.

H. Ohmori, I. Yamamoto, 1984, Immunopharmacology.

Augmentation of in vitro antibody response by disulfide compounds

H. Ohmori, I. Yamamoto, T. Yamauchi, 1982 .

Inhibition of free radical-induced erythrocyte hemolysis by 2-O-substituted ascorbic acid derivatives.

A. Tai, I. Yamamoto, E. Gohda, 2007, Free radical biology & medicine.

Radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl of ascorbic acid 2-glucoside (AA-2G) and 6-acyl-AA-2G.

A. Tai, I. Yamamoto, Y. Fujinami, 2001, Chemical & pharmaceutical bulletin.

Antiscorbutic activity of L-ascorbic acid 2-glucoside and its availability as a vitamin C supplement in normal rats and guinea pigs.

I. Yamamoto, S. Suga, N. Muto, 1990, Journal of pharmacobio-dynamics.

Development of a sensitive enzyme immunoassay for OPC-7251, a novel antimicrobial agent for percutaneous application.

I. Yamamoto, N. Muto, Y. Mitoh, 1990, Journal of immunoassay.

Potent xanthine oxidase inhibitors--4(or 5)-diazoimidazole-5(or 4)-carboxamide and two related compounds.

K. Muraki, H. Iwata, I. Yamamoto, 1969, Biochemical pharmacology.

Biological activity of diazonium compounds. II. Positive inoand chronotropic actions on guinea pig atria of 4(or 5)-diazo-imidazole-5(or 4)-carboxamide.

H. Iwata, I. Yamamoto, M. Oka, 1968, Japanese journal of pharmacology.

Potent competitive uricase inhibitors--2,8-diazahypoxanthine and related compounds.

H. Iwata, I. Yamamoto, M. Nakamura, 1973, Biochemical pharmacology.

Long-term radical scavenging activity of AA-2G and 6-acyl-AA-2G against 1,1-diphenyl-2-picrylhydrazyl.

A. Tai, I. Yamamoto, J. Takebayashi, 2002, Biological & pharmaceutical bulletin.

Protease-catalyzed monoacylation of 2-O-α-D-glucopyranosyl-l-ascorbic acid in pyridine

A. Tai, I. Yamamoto, S. Okazaki, 2001 .

Bioavailability and biological activity of L-ascorbic acid 2-O-α-glucoside in Proceeding of the 1st International Congress on Vitamins and Biofactors in Life Science in Kobe, 1991.

I. Yamamoto, 1992 .

Synthesis of 2-0-α-D-Glucopyranosyl L-Ascorbic Acid by Cyclomaltodextrin Glucanotransferase from Bacillus stearothermophilus

I. Yamamoto, Hajime Aga, S. Sakai, 1991 .

L-Ascorbic Acid α-Glucoside Formed by Regioselective Transglucosylation with Rat Intestinal and Rice Seed α-Glucosidases : Its Improved Stability and Structure Determination

I. Yamamoto, S. Suga, N. Muto, 1990 .

Formation of a Stable Ascorbic Acid 2-Glucoside by Specific Transglucosylation with Rice Seed α-Glucosidase

K. Goto, I. Yamamoto, S. Suga, 1990 .

Permeation and metabolism of a series of novel lipophilic ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids with a branched-acyl chain, in a human living skin equivalent model.

T. Nitoda, A. Tai, I. Yamamoto, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.

A. Tai, I. Yamamoto, K. Sasaki, 2002, Journal of medicinal chemistry.

The crystal structure and physicochemical properties of L-ascorbic acid 2-glucoside.

I. Yamamoto, N. Muto, S. Sakai, 1992, Carbohydrate research.

Formation of a stable l-ascorbic acid α-glucoside by mammalian α-glucosidase-catalyzed transglucosylation

I. Yamamoto, Tomoe Y. Nakamura, N. Muto, 1990 .

An isocratic HPLC method for the simultaneous determination of novel stable lipophilic ascorbic acid derivatives and their metabolites.

A. Tai, I. Yamamoto, E. Gohda, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Evaluation of ascorbic acid 2-O-alpha-glucoside as vitamin C source: mode of intestinal hydrolysis and absorption following oral administration.

I. Yamamoto, N. Muto, K. Terasawa, 1992, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

Vitamin C activity of 2-O-alpha-D-glucopyranosyl-L-ascorbic acid in guinea pigs.

I. Yamamoto, N. Arakawa, M. Akiba, 1992, Journal of nutritional science and vitaminology.

[Course in development of a stable vitamin C derivative (AA-2G)].

I. Yamamoto, 2008, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Ascorbic acid 2-O-alpha-glucoside, a stable form of ascorbic acid, rescues human keratinocyte cell line, SCC, from cytotoxicity of ultraviolet light B.

M. Yanagida, I. Yamamoto, E. Miyai, 1996, Biological & pharmaceutical bulletin.

Enzymatically modified Gc globulin induces the translocation of Fc.GAMMA.R I and Fc.GAMMA.RII from intracellular storage compartments to the cell surface in murine peritoneal macrophages.

I. Yamamoto, Takegi Ono, H. Ichikawa, 1995 .

Butyrate enhances the in vitro anti-SRBC (sheep red blood cell) antibody responses in murine splenocytes.

I. Yamamoto, M. Fujiwara, K. Ueda, 1994, Japanese journal of pharmacology.

Detection and clinical significance of acetoneinsoluble liver cell membrane antigen in sera of patients with chronic active liver diseases

E. Matsuura, I. Yamamoto, T. Tsuji, 1985, Gastroenterologia Japonica.

Parathyroid hormone down-regulates the epidermal growth factor receptors in clonal osteoblastic mouse calvarial cells, MC3T3-E1: possible mediation by adenosine 3'5'-cyclic monophosphate.

T. Yamamuro, I. Yamamoto, C. Shigeno, 1989, Endocrinology.

Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation.

I. Yamamoto, E. Gohda, T. Okamura, 1998, Biochemical pharmacology.

Molecular cloning, expression and purification of truncated midkine and its growth stimulatory activity on Wilms' tumor (G401) cells.

T. Shinozawa, I. Yamamoto, S. Paul, 2001, Cancer letters.

In vitro generation of antigen-specific suppressor T cell activity. Culture conditions for abrogating the induction of nonspecific suppressor T cells.

H. Ohmori, I. Yamamoto, T. Yamauchi, 1986, Journal of pharmacobio-dynamics.

Enzymatic formation of a nonreducing L-ascorbic acid alpha-glucoside: purification and properties of alpha-glucosidases catalyzing site-specific transglucosylation from rat small intestine.

T. Nakamura, I. Yamamoto, N. Muto, 1990, Journal of biochemistry.

Formation of a stable L-ascorbic acid alpha-glucoside by mammalian alpha-glucosidase-catalyzed transglucosylation.

Y. Suzuki, T. Nakamura, I. Yamamoto, 1990, Biochimica et biophysica acta.

L-ascorbic acid alpha-glucoside formed by regioselective transglucosylation with rat intestinal and rice seed alpha-glucosidases: its improved stability and structure determination.

I. Yamamoto, S. Suga, N. Muto, 1990, Chemical & pharmaceutical bulletin.

Interaction of rat brain cytidylate cyclase with phospholipids.

S. Mori, I. Yamamoto, N. Muto, 1989, Biochemical and biophysical research communications.

An enzyme immunoassay for K-76 monocarboxylic acid, a novel anticomplementary compound.

I. Yamamoto, S. Suga, N. Muto, 1989, Journal of immunoassay.

ENZYME IMMUNOASSAY OF CYCLIC NUCLEOTIDE

I. Yamamoto, J. Tsuji, 1980 .

In Vitro Augmentation of Natural Killer Activity and Interferon-γ Production in Murine Spleen Cells with Agaricus blazei Fruiting Body Fractions

A. Tai, I. Yamamoto, M. Zhong, 2005, Bioscience, biotechnology, and biochemistry.

Augmentation by Bursaphelenchus xylophilus, a pine wood nematode, of polyclonal IgE production induced by lipopolysaccharide plus interleukin-4 in murine splenocytes.

H. Kanzaki, A. Tai, I. Yamamoto, 2003, Journal of Pharmacological Sciences.

[Effects of hexobendine on adenosine metabolism and myocardial energy metabolism (author's transl)].

H. Iwata, I. Yamamoto, T. Masukawa, 1978, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.

I. Yamamoto, H. Kato, Y. Takata, 1985, Arzneimittel-Forschung.

Degradation of histamine in the presence of ascorbic acid and Cu2+ ion; involvement of hydrogen peroxide.

H. Ohmori, I. Yamamoto, 1981, Journal of pharmacobio-dynamics.

Inhibition of DNA synthesis of adult rat hepatocytes in primary culture by dibutyrylcytidine 3', 5'-cyclic monophosphate.

M. Yanagida, S. Mori, I. Yamamoto, 1989, Cell biology international reports.

[A case report of thyroid papillary cancer that manifested leukocytosis and hypercalcemia after radiotherapy in bone metastasis].

J. Konishi, I. Yamamoto, K. Kasagi, 1989, Gan no rinsho. Japan journal of cancer clinics.

Antigen-stimulated changes in cyclic nucleotide levels in the mouse.

D. Webb, I. Yamamoto, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Antigen-induced elevation of cyclic GMP level in plasma and its abolition in experimentally immunosuppressive mice.

N. Ishii, I. Yamamoto, 1982, Journal of Pharmacobio-Dynamics.

In vitro antagonism between cisplatin and vinca alkaloids.

I. Yamamoto, T. Hashimura, F. Kuze, 1989, British Journal of Cancer.

Characterization of the radical-scavenging reaction of 2-O-substituted ascorbic acid derivatives, AA-2G, AA-2P, and AA-2S: a kinetic and stoichiometric study.

A. Tai, I. Yamamoto, E. Gohda, 2006, Biological & pharmaceutical bulletin.

Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice.

T. Kobayashi, I. Yamamoto, M. Fujiwara, 1990, International journal of immunopharmacology.

Enzyme immunoassay for mabuterol, a selective beta 2-adrenergic stimulant in the trachea.

E. Matsuura, I. Yamamoto, T. Aizawa, 1985, Journal of immunoassay.

Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. II. A major role of the mixed disulfide between 2-mercaptoethanol and cysteine.

H. Ohmori, I. Yamamoto, 1983, Cellular immunology.

Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit.

I. Yamamoto, K. Iwata, M. Nakashima, 1985, Journal of pharmacobio-dynamics.

Enzyme immunoassay for clenbuterol, an beta 2-adrenergic stimulant.

I. Yamamoto, K. Iwata, 1982, Journal of immunoassay.

Development of radioimmunoassay for TG-51, a new anti-ulcer drug, and its application.

I. Yamamoto, S. Takahama, T. Naruchi, 1992, Journal of Immunoassay.

Development of enzyme immunoassay for Platonin (NK 19).

I. Yamamoto, K. Morishita, 1986, Journal of immunoassay.

Enzyme immunoassay for cytidine 3',5'-cyclic monophosphate (cyclic CMP).

I. Yamamoto, J. Tsuji, T. Takai, 1982, Immunopharmacology.

Increase in production of hepatocyte growth factor by human embryonic lung fibroblasts in the process of aging in culture.

K. Mihara, M. Namba, M. Miyazaki, 1994, Experimental cell research.

POSITIVE AND NEGATIVE REGULATION OF HGF GENE EXPRESSION

I. Yamamoto, E. Gohda, 1994 .

Activation of murine lymphocytes by 2-mercaptoethanol and related thiol compounds and its mechanism. I. Relationship between mitogenic activities and augmenting effects on antibody synthesis in vitro.

H. Ohmori, I. Yamamoto, 1981, Immunopharmacology.

Cyclic AMP and immune responses: changes in the splenic level of cyclic AMP during the response of mice to antigen.

T. Shimamura, I. Yamamoto, O. Plescia, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes: III. Serum-bound and oxidized 2-mercaptoethanol are available for the augmentation

H. Ohmori, I. Yamamoto, H. Ohmori, 1983 .

Cytidylate cyclase activity is stimulated via activation of a guanine nucleotide-binding protein.

I. Yamamoto, N. Muto, M. Kanoh, 1993, Life sciences.

An increase in histone acetylation and IL-2 antagonizing the immunoinhibitory effect are necessary for augmentation by butyrate of in vitro anti-TNP antibody production.

I. Yamamoto, E. Gohda, T. Okamura, 1999, Biological & pharmaceutical bulletin.

Annexin V assay-proven anti-apoptotic effect of ascorbic acid 2-glucoside after cold ischemia/reperfusion injury in rat liver transplantation.

N. Tanaka, T. Yagi, Jie Liu, 2003, Acta medica Okayama.

Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.

I. Yamamoto, J. Tsuji, K. Hirose, 1985, International journal of immunopharmacology.

SA96: an immunopharmacological profile in vitro.

H. Ohmori, I. Yamamoto, T. Okimura, 1982, International journal of tissue reactions.

Effect of N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA) on the induction of helper and suppressor T cells in vitro and in vivo.

H. Ohmori, I. Yamamoto, M. Sasano, 1983, Japanese journal of pharmacology.

Induction of prolonged elevation of interleukin 2 in the culture medium of murine splenocytes by their precultivation before mitogenic stimulations and its potentiation by glucocorticoid treatment and restraint stress loading.

I. Yamamoto, H. Shibata, 1990, Japanese journal of pharmacology.

Inhibitory effect of TI-31 on autoimmune nephritis in NZB/NZW F1 mice through regulation of the immune response.

I. Yamamoto, K. Hosoda, K. Komoriya, 1987, Immunopharmacology.

Antioxidant Activity of Glycosylated Vitamin P and Its Suppressive Effect on Oxidative Stress in Hyperlipidemic Mice

I. Yamamoto, H. Chaen, M. Yamada, 2003 .

Characterization of immunomodulating action of TI-31 on antibody response in mice.

I. Yamamoto, K. Komoriya, T. Takeshita, 1991, Journal of pharmacobio-dynamics.

Effect of TEI-3096 on experimental nephritis induced by calf serum in mice

I. Yamamoto, Y. Shiokawa, K. Komoriya, 1982 .

Vitamin C Activity in Guinea Pigs of 6-O-Acyl-2-O-α-D-glucopyranosyl-L- ascorbic Acids with a Branched-acyl Chain

A. Tai, I. Yamamoto, E. Gohda, 2003, Bioscience, biotechnology, and biochemistry.

Intramolecular acyl migration and enzymatic hydrolysis of a novel monoacylated ascorbic acid derivative, 6-O-dodecanoyl-2-O-alpha-d-glucopyranosyl-L-ascorbic acid.

Hideyuki Ito, A. Tai, I. Yamamoto, 2010, Bioorganic & medicinal chemistry.

Synthesis and Characterization of 6-O-Acyl-2-O-α-D-glucopyranosyl-L-ascorbic Acids with a Branched-Acyl Chain.

A. Tai, I. Yamamoto, E. Gohda, 2003 .

Synthesis and characterization of 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids with a branched-acyl chain.

A. Tai, I. Yamamoto, E. Gohda, 2003, Chemical & pharmaceutical bulletin.

Bioavailability of a Series of Novel Acylated Ascorbic Acid Derivatives, 6-O-Acyl-2-O-α-D-glucopyranosyl-L-ascorbic Acids, as an Ascorbic Acid…

A. Tai, I. Yamamoto, Kyoko Matsumoto, 2002 .

Bioavailability of a series of novel acylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as an ascorbic acid supplement in rats and guinea pigs.

A. Tai, I. Yamamoto, Kyoko Matsumoto, 2002, Bioscience, biotechnology and biochemistry.

EARLY CELLULAR EVENTS IN THE RESPONSE OF MICE TO SHEEP RED BLOOD CELLS REFLECTED BY CHANGES IN THE SPLEEN LEVEL OF CYCLIC AMP *

T. Shimamura, I. Yamamoto, Carl Feit, 1975, Annals of the New York Academy of Sciences.

Characterization of Bacillus stearothermophilus cyclodextrin glucanotransferase in ascorbic acid 2-O-alpha-glucoside formation.

I. Yamamoto, N. Muto, M. Tanaka, 1991, Biochimica et biophysica acta.

Evidence for the in vivo formation of ascorbic acid 2-O-alpha-glucoside in guinea pigs and rats.

I. Yamamoto, N. Muto, M. Akiba, 1991, Biochemical pharmacology.

2-O-α-D-Glucopyranosyl-L-ascorbic Acid Scavenges 1,1-Diphenyl-2-picrylhydrazyl Radicals via a Covalent Adduct Formation

A. Tai, I. Yamamoto, E. Gohda, 2007, Bioscience, biotechnology, and biochemistry.

[The current state on development of novel vitamin derivatives].

A. Tai, I. Yamamoto, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Synthesis of 2-O-α-d-Glucopyranosyll-Ascorbic Acid by Cyclomaltodextrin Glucanotransferase fromBacillus stearothermophilus

I. Yamamoto, S. Sakai, M. Yoneyama, 1991 .

Protease-catalyzed monoacylation of 2-O-alpha-D-Glucopyranosyl-L-ascorbic acid in pyridine.

A. Tai, I. Yamamoto, S. Okazaki, 2001, Chemical & pharmaceutical bulletin.

In situ intestinal absorption of 2-O-alpha-D-glucopyranosyl-L-ascorbic acid in guinea pigs.

I. Yamamoto, N. Arakawa, M. Akiba, 1995, Journal of nutritional science and vitaminology.

IgE production is involved in butyrate-enhanced NK cell activity in vivo.

A. Tai, I. Yamamoto, M. Zhong, 2001, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

Synergism between interferon-gamma and cAMP in induction of hepatocyte growth factor in human skin fibroblasts.

M. Miyazaki, I. Yamamoto, E. Gohda, 2000, Cytokine.

Abnormality of the delayed type hypersensitivity (DTH) response to Bordetella pertussis in spontaneously hypertensive rats (SHR).

I. Yamamoto, K. Komoriya, M. Tsuchimoto, 1984, Japanese journal of pharmacology.

Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma.

I. Yamamoto, E. Gohda, Yoichiro Takami, 2005, Biochemical and biophysical research communications.

Cytidylate cyclase activity in mouse tissues: the enzymatic conversion of cytidine 5'-triphosphate to cytidine 3',5'-cyclic monophosphate (cyclic CMP).

S. Mori, I. Yamamoto, T. Takai, 1989, Biochimica et biophysica acta.

A mechanism of the augmentation of antibody response in vitro by 2-mercaptoethanol: facilitation of cystine uptake in murine lymphocytes.

H. Ohmori, I. Yamamoto, 1982, International journal of immunopharmacology.

Enzyme immunoassays for beta-adrenoreceptor blocking agent, befunolol and its main metabolite, M1.

I. Yamamoto, S. Sato, 1983, Journal of immunoassay.

Double antibody enzyme immunoassay for the quantitation of adenosine 3', 5' -cyclic monophosphate (cyclic AMP) and guanosine 3', 5'-cyclic monophosphate (cyclic GMP) in tissue and plasma.

I. Yamamoto, M. Fujimoto, J. Tsuji, 1982, Journal of immunoassay.

Bioavailability and biological activity of L-ascorbic acid 2-O-alpha-glucoside.

I. Yamamoto, N. Muto, 1992, Journal of nutritional science and vitaminology.

Detection and clinical significance of acetoneinsoluble liver cell membrane antigen in sera of patients with chronic active liver diseases

E. Matsuura, I. Yamamoto, T. Tsuji, 1985, Gastroenterologia Japonica.

Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.

M. Miyazaki, H. Tsubouchi, I. Yamamoto, 2005, Biological & pharmaceutical bulletin.

Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin.

A. Tai, I. Yamamoto, E. Gohda, 2005, Biological & pharmaceutical bulletin.

Circulating oxidized LDL forms complexes with β2-glycoprotein I Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200329-JLR200

G. Hughes, M. Khamashta, T. Yasuda, 2003, Journal of Lipid Research.

Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. III. Serum-bound and oxidized 2-mercaptoethanol are available for the augmentation.

H. Ohmori, I. Yamamoto, 1983, Cellular immunology.

The use of beta-cyclodextrin in lymphocyte culture. Induction of the primary antibody response in vitro in calf serum- or newborn bovine serum-containing culture medium.

H. Ohmori, I. Yamamoto, M. Ienaga, 1987, Journal of pharmacobio-dynamics.

Immunomodulatory activity of the newly synthesized compound TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide).

I. Yamamoto, M. Fujiwara, K. Matsunari, 1989, Japanese journal of pharmacology.

Monoclonal antibody for calcitriol (l α,25-dihydroxyvitamin d3)

E. Matsuura, I. Yamamoto, 1985 .

Maintenance of glucose-sensitive insulin secretion of cryopreserved human islets with University of Wisconsin solution and ascorbic acid-2 glucoside.

N. Kobayashi, N. Tanaka, Kazuya Kobayashi, 2004, Artificial organs.

CuSO4 as an inhibitor of B cell proliferation.

I. Yamamoto, T. Yamauchi, 1990, Japanese journal of pharmacology.